SCHEMBL7606695

SCHEMBL7606695

O=C(O)Cc1cccnc1NP(=O)(O)Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
MAPT P10636 3/20 0.49
CYP1A2 P05177 1/20 0.49
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
LMNA P02545 1/20 0.38
GLA P06280 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
AKR1B1 P15121 2/20 0.38
NAPRT Q6XQN6 1/20 0.38
DHODH Q02127 1/20 0.38
BCAT2 O15382 1/20 0.38
DPP4 P27487 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
CFD P00746 1/20 0.37
PPIA P62937 2/20 0.36
FDPS P14324 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8427453 0.83 MAPT (0.39) MAPTKMT2AMEN1LMNAHTT
SCHEMBL8057238 0.76 CXCL8 (0.43) MAPTHTTAKR1B1CFDALDH1A1
SCHEMBL7609432 0.76 FDPS (0.40) KDM4EMAPTCYP1A2KMT2AMEN1
SCHEMBL8059092 0.76 NAPRT (0.51) CYP1A2KMT2AMEN1LMNAHTT
SCHEMBL7604654 0.74 HTT (0.37) KDM4EMAPTKMT2AMEN1LMNA
SCHEMBL7605064 0.74 KDM4E (0.46) KDM4EMAPTCYP1A2AKR1B1NAPRT
SCHEMBL7613594 0.74 GABRP (0.46) MAPTKMT2AMEN1AKR1B1NAPRT
SCHEMBL7746864 0.73 ALDH1A1 (0.44) KDM4EMAPTCYP1A2LMNAHTT
SCHEMBL7610263 0.72 HTT (0.36) KDM4EMAPTCYP1A2KMT2AMEN1
SCHEMBL7610525 0.72 MAPK8 (0.40) KMT2AMEN1AKR1B1BCAT2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
JP-2002514160-A 2002-05-14 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP claimed
EP-0936914-A4 1999-08-25 EP claimed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed
EP-0936914-A4 1999-08-25 EP disclosed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP disclosed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO disclosed